ETF Components for ILOW - AB International Low Volatility Equity ETF


Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

Holdings

Symbol Grade Price % Change Allocation
SMFG B 0.85 1.76
HMC F -0.08 1.65
MUFG B 0.47 1.60
PM A 0.29 1.44
NVS D 0.32 0.99
ABBV F -0.04 0.93
CNI F 0.43 0.89
DOX D 0.39 0.81
BKNG A 0.67 0.72
LOGI F 1.27 0.70

Recent News for AB International Low Volatility Equity ETF & its Holdings

Date Stock Title
Nov 21 PM Mohamed El-Erian Warns Against Simplistic Narratives As Trump Plans Aggressive Tariff Strategy: 'The Issue Is Quite Complex'
Nov 21 HMC Honda hopes to double EV driving range with solid-state batteries, R&D chief says
Nov 21 BKNG Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
Nov 20 LOGI Logitech slips even as UBS upgrades on 'balanced' risk-reward
Nov 20 ABBV Unpacking the Latest Options Trading Trends in AbbVie
Nov 20 BKNG Is BARK (BARK) Stock Outpacing Its Retail-Wholesale Peers This Year?
Nov 20 HMC Toyota Plunges 20% in 6 Months: At a Low P/E, is TM Stock a Buy Now?
Nov 20 DOX We Think You Can Look Beyond Amdocs' (NASDAQ:DOX) Lackluster Earnings
Nov 20 BKNG Booking Holdings Inc. (BKNG): Among Harvard University’s Top Stock Picks
Nov 19 BKNG Affirm & Priceline Expand Partnership to Offer Pay Over Time Solutions
Nov 19 ABBV ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap
Nov 19 ABBV Where Will AbbVie Be in 5 Years?
Nov 19 SMFG SMBC MANUBANK Announces Multiple Key Hires Across Credit, Accounting, and Technology Functions to Support Growth
Nov 19 BKNG OpenTable Serves Up 2025 Dining Predictions
Nov 19 NVS Novartis ranks first in 2024 Access to Medicine Index
Nov 19 NVS Novartis strengthens radiopharma leadership with Ratio Therapeutics deal
Nov 19 BKNG Affirm to serve as pay-over-time provider for Priceline Partner Solutions
Nov 19 NVS Astellas application rejected by FDA; Cytokinetics strikes licensing deal with Bayer
Nov 19 ABBV RVPH: Year-End OLE Update
Nov 19 ABBV What is a ‘cure,’ really? AbbVie’s Humira creator leaps into the next phase of medicine
The adviser seeks to achieve the fund"s investment objective by investing, under normal circumstances, at least 80% of its net assets, including any borrowings for investment purposes, in equity securities of non-U.S. companies, and in companies in at least three countries other than the United States. It invests in companies that are determined by the adviser to offer favorable long-term sustainable profitability, price stability, and attractive valuations.
Index Fund Venture Capital
Back to the Main ILOW Page...